• No results found

Response To Interferon Therapy

Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population

Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population

... Treatment outcome in relation to PKRBD sequence A 416 bp fragment of the NS5A region covering ISDR and PKRBD was sequenced to find out differences in the number of mutations in SVR and non-SVR patients. These sequences ...

8

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?

... IFN: Interferon; HCV: Hepatitis C Virus; GWAS: Genome Wide Association Studies; PegIFN- α -2a: Peginterferon- α -2a; PegIFN- α -2b: Peginterferon- α -2b; RBV: Ribavirin; SVR: Sustained Viral Response; EtBr: ...

6

STUDY THE EXPRESSION OF TETRASPANIN (CD81) ON B CELLS IN RESPONSE TO INTERFERON THERAPY IN CHRONIC HCV PATIENTS

STUDY THE EXPRESSION OF TETRASPANIN (CD81) ON B CELLS IN RESPONSE TO INTERFERON THERAPY IN CHRONIC HCV PATIENTS

... with interferon (INF) - alpha combined with ribavirin is aimed at viral clearance, Interferon and ribavirin might discontinue the virus induced hepatocytes damage, thus slowing down the progress to end- ...

6

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

... additional therapy remain alive without recurrence of hepatocellular ...additional therapy showed long survival (1326 days and 1280 ...additional therapy preceded by downstaging of hepatocellular ...

8

HCV NS5A region and response to pegylated interferon alpha plus ribavirin therapy: mutational analyses in patients with chronic HCV infection

HCV NS5A region and response to pegylated interferon alpha plus ribavirin therapy: mutational analyses in patients with chronic HCV infection

... to therapy and 6 did not ...the therapy and to determine the efficacy of the ...higher response to therapy than genotype 1 is in accordance to previous reports which observed that virological ...

10

A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients

A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients

... by interferon may influence both transcrip- tional and post-transcriptional regulation ...of interferon is through the activation of JAK-STAT signal transduction ...pathways. Interferon induces the ...

6

Monitoring the Treatment of Hepatitis C Viral Infection by Molecular Techniques

Monitoring the Treatment of Hepatitis C Viral Infection by Molecular Techniques

... combination therapy of peglated interferon plus ribavirin (PEG-interferon α ...to interferon therapy was made based on earlier studies where conventional interferon-alpha (INF- α ...

10

Effect of adjuvant interferon therapy on hepatitis B virus related hepatocellular carcinoma: a systematic review

Effect of adjuvant interferon therapy on hepatitis B virus related hepatocellular carcinoma: a systematic review

... rologic response rate was only 25 % [29]. But, the main effects of interferon are antiviral, immune regulation, and antiproliferative agents rather than the integration of HBV gene inhibitors ...[30]. ...

8

Identifying responders and nonresponders to interferon therapy in multiple sclerosis

Identifying responders and nonresponders to interferon therapy in multiple sclerosis

... or response, and linked with each other in a network, indicating that they also relate to each other at a functional ...in response to treatment with ...

10

AMINO ACID SEQUENCE VARIATIONS WITHIN ENVELOPED PROTEIN 2 (E2) OF HEPATITIS C VIRUS SUBTYPE 3a AND RESPONSE TO INTERFERON ALPHA PLUS RIBAVIRIN COMBINATION THERAPY

AMINO ACID SEQUENCE VARIATIONS WITHIN ENVELOPED PROTEIN 2 (E2) OF HEPATITIS C VIRUS SUBTYPE 3a AND RESPONSE TO INTERFERON ALPHA PLUS RIBAVIRIN COMBINATION THERAPY

... with Interferon therapy most of the previous studies were focused on the Interferon sensitive determining region (ISDR) from non structure protein 5A (NS5A) and RNA-dependent protein kinase ...

12

The Antiviral Response to Gamma Interferon

The Antiviral Response to Gamma Interferon

... alpha/beta interferon (IFN- ␣ / ␤ ) in the IFN- ␥ antiviral response has long been ...␥ response were ...␥ response per se dependent on autocrine IFN- ␣ / ␤ ...␤ response; these include ...

9

Prediction of response to pegylated interferon α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype

Prediction of response to pegylated interferon α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype

... the therapy, the patients were followed- up for 24 weeks and the therapeutic effectiveness was ...from therapy due to undesirable side effects were ...

6

Sustained Biochemical and Virological Response of Different HCV Genotypes to Interferon-Alpha Plus Ribavirin Combination Therapy

Sustained Biochemical and Virological Response of Different HCV Genotypes to Interferon-Alpha Plus Ribavirin Combination Therapy

... EOT response was low as compare to those in which the both genotypes were ...with interferon-alpha therapy in patients with hepatitis ...sustained response had no detectable liver HCV RNA 1 to ...

9

Induction of Host Gene Expression following Infection of Chicken Embryo Fibroblasts with Oncogenic Marek's Disease Virus

Induction of Host Gene Expression following Infection of Chicken Embryo Fibroblasts with Oncogenic Marek's Disease Virus

... protein, interferon response factor 1, interferon-inducible protein, quiescence-specific protein, thymic shared antigen 1, major histocompatibility complex (MHC) class I, MHC class II, ␤ 2 ...

7

Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report

Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report

... of interferon alpha on the immune system that leads to its therapeutic actions are also re- sponsible for the development of ...to interferon alpha receptors, which are transmembrane ...

5

Natural killer cell in systemic lupus erythematosus  Defects in effector lytic activity and response to interferon and interferon inducers

Natural killer cell in systemic lupus erythematosus Defects in effector lytic activity and response to interferon and interferon inducers

... Spontaneous cytotoxicity mediated by natural killer (NK) cells is impaired in several human diseases including systemic lupus erythematosus (SLE). The precise mechanism(s) by which NK activity is suppressed in patients ...

11

Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population based cohort study in Taiwan

Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population based cohort study in Taiwan

... in response to microorganism infections and play a crucial role in innate immune activity against viruses ...immune response and is essential in the control of mycobacterial infection in both animal models ...

8

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders

... viral response rates in injection drug users still actively using ...antiviral therapy in substance users, the sustained viral response (SVR) and adherence rates were not different from non- drug ...

8

Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy

Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy

... of therapy because this assay is more ...(B) therapy. Correlations were good both before and 24 h after therapy (r ⫽ ...after therapy than before therapy (P ⬍ ...

6

Cell-Specific Regulation of Nucleic Acid Sensor Cascades: a Controlling Interest in the Antiviral Response

Cell-Specific Regulation of Nucleic Acid Sensor Cascades: a Controlling Interest in the Antiviral Response

... early response to virus infection in MS1 cells may indicate that endothelial cells operate with a higher threshold for antiviral activation in comparison to ...early response to rAd5CiG leading to IRF3 ...

10

Show all 10000 documents...

Related subjects